+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

2019 Influenza A Virus H3N2 Subtype Infections R&D Pipeline Drugs, Companies, Trials and Developments - Product Thumbnail Image

2019 Influenza A Virus H3N2 Subtype Infections R&D Pipeline Drugs, Companies, Trials and Developments

  • Report
  • March 2019
  • 120 pages
From
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 - Product Thumbnail Image

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021

  • Report
  • April 2021
  • 900 Pages
From
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 - Product Thumbnail Image

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021

  • Report
  • April 2021
  • 1200 Pages
From
AI-based Drug Discovery Market: Focus on Deep Learning and Machine Learning, 2020-2030 - Product Thumbnail Image

AI-based Drug Discovery Market: Focus on Deep Learning and Machine Learning, 2020-2030

  • Report
  • January 2021
  • 294 Pages
From
2019 Future of Spinal Muscular Atrophy (SMA) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments - Product Thumbnail Image

2019 Future of Spinal Muscular Atrophy (SMA) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

  • Report
  • February 2019
  • 95 pages
From
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2021 - Product Thumbnail Image

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2021

  • Report
  • April 2021
  • 500 pages
From
Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 - Product Thumbnail Image

Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021

  • Report
  • March 2021
  • 1500 pages
From
Restenosis Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Restenosis Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • June 2018
  • 99 pages
From
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2021 - Product Thumbnail Image

Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2021

  • Report
  • April 2021
  • 650 Pages
From
Global Central Nervous System Partnering 2014-2021: Deal Trends, Players and Financials - Product Thumbnail Image

Global Central Nervous System Partnering 2014-2021: Deal Trends, Players and Financials

  • Report
  • April 2021
  • 1000 pages
From
Global Big Pharma Partnering Terms and Agreements 2014-2021 - Product Thumbnail Image

Global Big Pharma Partnering Terms and Agreements 2014-2021

  • Report
  • March 2021
  • 2200 pages
From
Global Genetic Disorders Partnering 2014-2021: Deal Trends, Players and Financials - Product Thumbnail Image

Global Genetic Disorders Partnering 2014-2021: Deal Trends, Players and Financials

  • Report
  • April 2021
  • 400 Pages
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
From
Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 - Product Thumbnail Image

Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021

  • Report
  • March 2021
  • 1800 pages
From
Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026 - Product Thumbnail Image

Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026

  • Report
  • January 2020
  • 1500 Pages
From
COVID-19 Therapy and Vaccine Drug Pipeline Market Report- 2021 Update - Product Thumbnail Image

COVID-19 Therapy and Vaccine Drug Pipeline Market Report- 2021 Update

  • Report
  • January 2021
  • 500 Pages
From
Global CRISPR Cas9 Market, Clinical Trials & Therapeutic Application Outlook 2024 - Product Thumbnail Image

Global CRISPR Cas9 Market, Clinical Trials & Therapeutic Application Outlook 2024

  • Report
  • October 2019
From
COVID-19 Therapy and Vaccine Drug Pipeline Market Report - September 2020 Update - Product Thumbnail Image

COVID-19 Therapy and Vaccine Drug Pipeline Market Report - September 2020 Update

  • Report
  • September 2020
  • 512 Pages
From
COVID Treatment and Vaccine Drug Pipeline Report- July 2020 Update - Product Thumbnail Image

COVID Treatment and Vaccine Drug Pipeline Report- July 2020 Update

  • Report
  • July 2020
  • 170 Pages
From
Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines - Product Thumbnail Image

Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines

  • Report
  • May 2021
  • 62 pages
From
Loading Indicator
adroll